ConductScience.org, home
PIEZO1: piezo type mechanosensitive ion channel component 1 (Er blood group)
API referenceFor AI assistants

Gene · 9780

Papers3,250

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

41 to 60 of 3,250

Download this page as JSON
TitleJournalYearPMIDFound bySource
Dynamic Compression Reveals Donor-Age-Associated Inflammaging in Human Mesenchymal Stromal Cell Spheroids.ACS Appl Mater Interfaces202642696704PubTator, text miningPubMed
The Role of Biomechanical Regulation in Physiological and Pathological Pregnancy: From Mechanotransduction to Clinical Implications.Int J Biol Sci202642694978PubTator, text miningPubMed
Piezo1 in intestinal epithelial cells plays a critical role in the mechanobiological positive feedback underlying intestinal fibrosis.J Crohns Colitis202642692544PubTator, text miningPubMed
Piezo1 agonists are potent off-target inhibitors of the Kv1.3 channel via gating modification.Mol Pharmacol202642691696PubTator, text miningPubMed
PIEZO Channels in Metabolism and Metabolic Diseases: Research Advances and Therapeutic Strategies.Curr Obes Rep202642690495PubTator, text miningPubMed
Mechanosensing channels PIEZO1 and PIEZO2 regulate mitral valve serotonin-mediated homeostasis and pathophysiology.Cardiovasc Res202642687771PubTator, text miningPubMed
M-SYFSF attenuates diabetic kidney disease by suppressing Piezo1-associated cGAS-STING signalling and tubular pyroptosis.Phytomedicine202642685564PubTator, text miningPubMed
Preoperative Prediction of Meningioma Consistency, Adhesion, and Biomarker Status Using Whole-Tumor MR Elastography Histogram Analysis.Acad Radiol202642680661PubTator, text miningPubMed
Piezo1 and Piezo2 in neurological disorders: From mechanotransduction to therapeutic potential.Curr Opin Pharmacol202642679748PubTator, text miningPubMed
Corticosteroid-induced alterations in cytoskeletal organization and mechanosensing of osteoarthritic synoviocytes.Eur J Cell Biol202642679564PubTator, text miningPubMed
Reciprocal Coupling among Extracellular Matrix Mechanics, Mechanosensitive Ion Channels, and Cell Remodeling Behaviors.ACS Appl Mater Interfaces202642675897PubTator, text miningPubMed
CD266+ Myofibroblasts Mediate Resistance to Immunochemotherapy through ECM Stiffness in Head and Neck Squamous Cell Carcinoma.Cancer Immunol Res202642671928PubTator, text miningPubMed
Engineering Piezo1-Mediated Calcium Signalling for Enhanced Extracellular Vesicle Biogenesis and Cargo Loading.J Extracell Biol202642669009PubTator, text miningPubMed
Hardened ground: ECM stiffness as a unifying biomechanical driver of reproductive stem cell aging.Biogerontology202642663744PubTator, text miningPubMed
[Advances in mechanical signal-regulated tumor immunity and its therapeutic development].Zhejiang Da Xue Xue Bao Yi Xue Ban202642663108PubTator, text miningPubMed
From mechanical adaptation to innate immune reprogramming in osteoarthritis: a load-immunity framework.Front Immunol202642662120PubTator, text miningPubMed
Type I collagen matrix signaling in cancer: receptor sensing and mechanotransduction.Cell Signal202642660397PubTator, text miningPubMed
Programmable magnetic bioactivation: alternating fields as remote controllers of regenerative signaling.Chem Commun (Camb)202642658534PubTator, text miningPubMed
Piezo1 Mechanotransduction in Skeletal Muscle: Convergence with Noncoding RNA Regulation in Myogenesis, Regeneration, and Sarcopenia.Int J Mol Sci202642653088PubTator, text miningPubMed
State-dependent binding of the wedge domain controls inactivation of the mechanosensitive ion channel PIEZO1.Nat Commun202642649207PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Previous pageNext page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/9780/papers?page=3

API referenceFor AI assistants